🕵️ Immunic, Inc. ($IMUX)
SEC insider & ownership activity, last 12 months · CIK 1280776 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Janus Henderson Group PLC added 3.0% → 10.0%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 10.0% | 13G | Dec 8, 2025 | filing ↗ | |
| VIVO Opportunity Fund Holdings, L.P. | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| VIVO Opportunity, LLC | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| VIVO Opportunity Cayman Fund, L.P. | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| VIVO Opportunity Cayman, LLC | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| BVF Partners L P/IL | 10.0% | 13D | Feb 12, 2026 | filing ↗ | |
| BVF INC/IL | 10.0% | 13D | Feb 12, 2026 | filing ↗ | |
| Mark N. Lampert | 10.0% | 13D | Feb 12, 2026 | filing ↗ | |
| Adage Capital Management, L.P. | 10.0% | 13G | Aug 12, 2025 | filing ↗ | |
| Robert Atchinson | 10.0% | 13G | Aug 12, 2025 | filing ↗ | |
| Phillip Gross | 10.0% | 13G | Aug 12, 2025 | filing ↗ | |
| Commodore Capital LP | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Commodore Capital Master LP | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Robert Egen Atkinson | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Michael Kramarz | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Avidity Partners Management LP | 9.9% | 13G | Apr 17, 2026 | filing ↗ | |
| Avidity Partners Management (GP) LLC | 9.9% | 13G | Apr 17, 2026 | filing ↗ | |
| Avidity Capital Partners Fund (GP) LP | 9.9% | 13G | Apr 17, 2026 | filing ↗ | |
| Avidity Capital Partners (GP) LLC | 9.9% | 13G | Apr 17, 2026 | filing ↗ | |
| Avidity Private Master Fund I LP | 9.9% | 13G | Apr 17, 2026 | filing ↗ | |
| Michael Gregory | 9.9% | 13G | Apr 17, 2026 | filing ↗ | |
| BVF GP Holdings LLC | 9.6% | 13D | Feb 12, 2026 | filing ↗ | |
| Trails EDGE Capital Partners, LP | 8.7% | 13G | Feb 24, 2026 | filing ↗ | |
| Trails EDGE Biotechnology Master Fund, LP | 8.7% | 13G | Feb 24, 2026 | filing ↗ | |
| Ortav Yehudai | 8.7% | 13G | Feb 24, 2026 | filing ↗ | |
| DEEP Track Capital, LP | 8.7% | 13G | Mar 4, 2026 | filing ↗ | |
| David Kroin | 8.7% | 13G | Mar 4, 2026 | filing ↗ | |
| Abrdn Inc | 8.6% | 13G | Jul 31, 2025 | filing ↗ | |
| Nantahala Capital Management, LLC | 7.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Wilmot B. Harkey | 7.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Daniel Mack | 7.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Biotechnology Value Fund L P | 7.4% | 13D | Feb 12, 2026 | filing ↗ | |
| BVF I GP LLC | 7.4% | 13D | Feb 12, 2026 | filing ↗ | |
| Millennium Management LLC | 7.0% | 13G | Aug 6, 2026 | filing ↗ | |
| Millennium Group Management LLC | 7.0% | 13G | Aug 6, 2026 | filing ↗ | |
| Israel A. Englander | 7.0% | 13G | Aug 6, 2026 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | 6.9% | 13G | Aug 6, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 6.8% | 13G | Mar 4, 2026 | filing ↗ | |
| Avidity Partners Management LP | 6.6% | 13G | May 15, 2025 | filing ↗ | |
| Avidity Partners Management (GP) LLC | 6.6% | 13G | May 15, 2025 | filing ↗ | |
| Avidity Capital Partners Fund (GP) LP | 6.6% | 13G | May 15, 2025 | filing ↗ | |
| Avidity Capital Partners (GP) LLC | 6.6% | 13G | May 15, 2025 | filing ↗ | |
| Michael Gregory | 6.6% | 13G | May 15, 2025 | filing ↗ | |
| Laurion Capital Management LP | 6.1% | 13G | Aug 4, 2026 | filing ↗ | |
| Benjamin Alexander Smith | 6.1% | 13G | Aug 4, 2026 | filing ↗ | |
| Janaka Sheehan Maduraperuma | 6.1% | 13G | Aug 4, 2026 | filing ↗ | |
| Aberdeen Group PLC | 6.0% | 13G | Jul 16, 2026 | filing ↗ | |
| Abrdn Inc. | 6.0% | 13G | Jul 16, 2026 | filing ↗ | |
| OrbiMed Advisors LLC | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| OrbiMed Genesis GP LLC | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Avidity Private Master Fund I LP | 5.2% | 13G | May 15, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Sep 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2026 | filing ↗ |
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 16, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 24, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Apr 22, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 22, 2026 | filing ↗ |
| Other events (8.01) | Apr 22, 2026 | filing ↗ |